{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,10]],"date-time":"2026-10-10T22:11:07Z","timestamp":1791670267217,"version":"4.3.4"},"reference-count":31,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,5,1]],"date-time":"2024-05-01T00:00:00Z","timestamp":1714521600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,5,1]],"date-time":"2024-05-01T00:00:00Z","timestamp":1714521600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,5,1]],"date-time":"2024-05-01T00:00:00Z","timestamp":1714521600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,5,1]],"date-time":"2024-05-01T00:00:00Z","timestamp":1714521600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,5,1]],"date-time":"2024-05-01T00:00:00Z","timestamp":1714521600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,5,1]],"date-time":"2024-05-01T00:00:00Z","timestamp":1714521600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,5,1]],"date-time":"2024-05-01T00:00:00Z","timestamp":1714521600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The American Journal of Emergency Medicine"],"published-print":{"date-parts":[[2024,5]]},"DOI":"10.1016\/j.ajem.2024.01.048","type":"journal-article","created":{"date-parts":[[2024,2,10]],"date-time":"2024-02-10T02:47:28Z","timestamp":1707533248000},"page":"58-62","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"special_numbering":"C","title":["Differentiating hidradenitis suppurativa flare from infection in the emergency department and recommendations for transitioning care to the outpatient setting"],"prefix":"10.1016","volume":"79","author":[{"given":"Soumya","family":"Reddy","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gabrielle","family":"Schwartzman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lydia A.","family":"Luu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Grace","family":"Im","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R. Hal","family":"Flowers","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Darren J.","family":"Guffey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"3","key":"10.1016\/j.ajem.2024.01.048_bb0005","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1016\/j.jaad.2012.07.027","article-title":"Analysis of patient claims data to determine the prevalence of hidradenitis suppurativa in the United States","volume":"68","author":"Cosmatos","year":"2013","journal-title":"J Am Acad Dermatol"},{"issue":"8","key":"10.1016\/j.ajem.2024.01.048_bb0010","doi-asserted-by":"crossref","first-page":"760","DOI":"10.1001\/jamadermatol.2017.0201","article-title":"Sex- and age-adjusted population analysis of prevalence estimates for hidradenitis Suppurativa in the United States","volume":"153","author":"Garg","year":"2017","journal-title":"JAMA Dermatol"},{"issue":"2","key":"10.1016\/j.ajem.2024.01.048_bb0015","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1016\/j.jaad.2019.06.1301","article-title":"Evaluating patients\u2019 unmet needs in hidradenitis suppurativa: results from the global survey of impact and healthcare needs (VOICE) project","volume":"82","author":"Garg","year":"2020","journal-title":"J Am Acad Dermatol"},{"issue":"4","key":"10.1016\/j.ajem.2024.01.048_bb0020","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1111\/j.1440-0960.2005.00189.x","article-title":"Assessing diagnostic skill in dermatology: a comparison between general practitioners and dermatologists","volume":"46","author":"Tran","year":"2005","journal-title":"Australas J Dermatol"},{"issue":"2","key":"10.1016\/j.ajem.2024.01.048_bb0025","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1067\/mjd.2001.114598","article-title":"Dermatology in primary care: prevalence and patient disposition","volume":"45","author":"Lowell","year":"2001","journal-title":"J Am Acad Dermatol"},{"issue":"12","key":"10.1016\/j.ajem.2024.01.048_bb0030","doi-asserted-by":"crossref","first-page":"1404","DOI":"10.1001\/jamadermatol.2022.4564","article-title":"Evaluation of hidradenitis Suppurativa diagnostic criteria in pediatric patients","volume":"158","author":"Kittler","year":"2022","journal-title":"JAMA Dermatol"},{"issue":"5","key":"10.1016\/j.ajem.2024.01.048_bb0035","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1159\/000511077","article-title":"Development and validation of HSCAPS-1: a clinical decision support tool for diagnosis of hidradenitis Suppurativa over cutaneous abscess","volume":"237","author":"Garg","year":"2021","journal-title":"Dermatology (Basel, Switzerland)"},{"key":"10.1016\/j.ajem.2024.01.048_bb0040","doi-asserted-by":"crossref","DOI":"10.1111\/pde.15231","article-title":"Pediatric hidradenitis suppurativa: describing care patterns in the emergency department","author":"Lambert","year":"2023","journal-title":"Pediatr Dermatol"},{"issue":"4","key":"10.1016\/j.ajem.2024.01.048_bb0045","doi-asserted-by":"crossref","first-page":"1006","DOI":"10.1016\/j.jaad.2019.10.044","article-title":"Hidradenitis suppurativa and smoking: a systematic review and meta-analysis","volume":"82","author":"Acharya","year":"2020","journal-title":"J Am Acad Dermatol"},{"issue":"5","key":"10.1016\/j.ajem.2024.01.048_bb0050","doi-asserted-by":"crossref","first-page":"1092","DOI":"10.1016\/j.jaad.2021.01.059","article-title":"Comorbidity screening in hidradenitis suppurativa: evidence-based recommendations from the US and Canadian hidradenitis Suppurativa foundations","volume":"86","author":"Garg","year":"2022","journal-title":"J Am Acad Dermatol"},{"issue":"5","key":"10.1016\/j.ajem.2024.01.048_bb0055","doi-asserted-by":"crossref","first-page":"636","DOI":"10.1016\/j.jemermed.2022.08.001","article-title":"Hidradenitis Suppurativa: diagnosis and Management in the Emergency Department","volume":"63","author":"Okun","year":"2022","journal-title":"J Emerg Med"},{"issue":"1","key":"10.1016\/j.ajem.2024.01.048_bb0060","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1016\/j.jaad.2019.02.067","article-title":"North American clinical management guidelines for hidradenitis suppurativa: a publication from the United States and Canadian hidradenitis Suppurativa foundations: part I: diagnosis, evaluation, and the use of complementary and procedural management","volume":"81","author":"Alikhan","year":"2019","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.ajem.2024.01.048_bb0065","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/j.jdin.2022.04.005","article-title":"Erythrocyte sedimentation rate, rather than C-reactive protein, may be the preferred biomarker for hidradenitis suppurativa","volume":"8","author":"Gibson","year":"2022","journal-title":"JAAD Intern"},{"issue":"6","key":"10.1016\/j.ajem.2024.01.048_bb0070","doi-asserted-by":"crossref","first-page":"998","DOI":"10.1016\/j.jaad.2015.08.052","article-title":"Correlation of inflammatory serum markers with disease severity in patients with hidradenitis suppurativa (HS)","volume":"73","author":"Hessam","year":"2015","journal-title":"J Am Acad Dermatol"},{"issue":"2","key":"10.1016\/j.ajem.2024.01.048_bb0075","doi-asserted-by":"crossref","DOI":"10.1111\/dth.14835","article-title":"Evaluation of the laboratory parameters in hidradenitis suppurativa: can we use new inflammatory biomarkers?","volume":"34","author":"\u00c7etinarslan","year":"2021","journal-title":"Dermatol Ther"},{"issue":"22","key":"10.1016\/j.ajem.2024.01.048_bb0080","doi-asserted-by":"crossref","first-page":"13800","DOI":"10.3390\/ijms232213800","article-title":"Serum immunoglobulin G is a marker of hidradenitis Suppurativa disease severity","volume":"23","author":"Mintoff","year":"2022","journal-title":"Int J Mol Sci"},{"issue":"4","key":"10.1016\/j.ajem.2024.01.048_bb0085","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1136\/ard.62.4.337","article-title":"Can procalcitonin measurement help in differentiating between bacterial infection and other kinds of inflammatory processes?","volume":"62","author":"Del\u00e8vaux","year":"2003","journal-title":"Ann Rheum Dis"},{"issue":"3","key":"10.1016\/j.ajem.2024.01.048_bb0090","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1001\/jamadermatol.2021.4926","article-title":"Identification of biomarkers and critical evaluation of biomarker validation in hidradenitis Suppurativa: a systematic review","volume":"158","author":"Der Sarkissian","year":"2022","journal-title":"JAMA Dermatol"},{"issue":"1","key":"10.1016\/j.ajem.2024.01.048_bb0095","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1111\/srt.12759","article-title":"Hidradenitis suppurativa: current understanding, diagnostic and surgical challenges, and developments in ultrasound application","volume":"26","author":"Elkin","year":"2020","journal-title":"Skin Res Technol: Off J Intern Soc Bioeng Skin (ISBS) [and] Intern Soc Digi Imag Skin (ISDIS) [and] Intern Soc Skin Imag (ISSI)"},{"key":"10.1016\/j.ajem.2024.01.048_bb0100","article-title":"The use of ultrasound and MRI in the management of hidradenitis suppurativa: a narrative review","volume":"ljad028","author":"Mendes-Bastos","year":"2023","journal-title":"Br J Dermatol"},{"issue":"1","key":"10.1016\/j.ajem.2024.01.048_bb0105","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1001\/jamadermatol.2020.4494","article-title":"Pain severity and Management of Hidradenitis Suppurativa at US emergency department visits","volume":"157","author":"Taylor","year":"2021","journal-title":"JAMA Dermatol"},{"issue":"12","key":"10.1016\/j.ajem.2024.01.048_bb0110","doi-asserted-by":"crossref","first-page":"1378","DOI":"10.1001\/jamadermatol.2022.4610","article-title":"Factors associated with dermatologic follow-up vs emergency department return in patients with hidradenitis Suppurativa after an initial emergency department visit","volume":"158","author":"Wang","year":"2022","journal-title":"JAMA Dermatol"},{"issue":"11","key":"10.1016\/j.ajem.2024.01.048_bb0115","doi-asserted-by":"crossref","first-page":"1284","DOI":"10.1001\/jamadermatol.2019.2610","article-title":"Incidence of long-term opioid use among opioid-naive patients with hidradenitis Suppurativa in the United States","volume":"155","author":"Reddy","year":"2019","journal-title":"JAMA Dermatol"},{"issue":"4","key":"10.1016\/j.ajem.2024.01.048_bb0120","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1111\/jdv.12966","article-title":"European S1 guideline for the treatment of hidradenitis suppurativa\/acne inversa","volume":"29","author":"Zouboulis","year":"2015","journal-title":"J Eur Acad Dermatol Venereol: JEADV"},{"issue":"2","key":"10.1016\/j.ajem.2024.01.048_bb0125","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1111\/ijd.15124","article-title":"Efficacy of high-dose intralesional triamcinolone for hidradenitis suppurativa","volume":"60","author":"Garelik","year":"2021","journal-title":"Int J Dermatol"},{"key":"10.1016\/j.ajem.2024.01.048_bb0130","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/j.det.2015.08.007","article-title":"Surgical procedures in hidradenitis suppurativa","volume":"34","author":"Janse","year":"2016","journal-title":"Dermatol Clin"},{"key":"10.1016\/j.ajem.2024.01.048_bb0135","doi-asserted-by":"crossref","first-page":"1030","DOI":"10.1097\/DSS.0000000000000806","article-title":"Surgical management of hidradenitis suppurativa: outcomes of 590 consecutive patients","volume":"42","author":"Kohorst","year":"2016","journal-title":"Dermatologic Surg"},{"key":"10.1016\/j.ajem.2024.01.048_bb0140","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1111\/j.1524-4725.2011.02186.x","article-title":"Hidradenitis suppurativa: surgical and other management techniques","volume":"38","author":"Ellis","year":"2012","journal-title":"Dermatologic Surg"},{"issue":"9","key":"10.1016\/j.ajem.2024.01.048_bb0145","doi-asserted-by":"crossref","first-page":"937","DOI":"10.1001\/jamadermatol.2014.691","article-title":"Health care utilization patterns and costs for patients with hidradenitis suppurativa","volume":"150","author":"Kirby","year":"2014","journal-title":"JAMA Dermatol"},{"issue":"2","key":"10.1016\/j.ajem.2024.01.048_bb0150","first-page":"114","article-title":"What is hidradenitis suppurativa?","volume":"63","author":"Lee","year":"2017","journal-title":"Can Fam Physician"},{"issue":"1","key":"10.1016\/j.ajem.2024.01.048_bb0155","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1016\/j.ajog.2020.09.036","article-title":"Diagnosis and management of hidradenitis suppurativa in women","volume":"224","author":"Collier","year":"2021","journal-title":"Am J Obstet Gynecol"}],"container-title":["The American Journal of Emergency Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0735675724000639?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0735675724000639?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,9]],"date-time":"2025-10-09T16:08:55Z","timestamp":1760026135000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0735675724000639"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,5]]},"references-count":31,"alternative-id":["S0735675724000639"],"URL":"https:\/\/doi.org\/10.1016\/j.ajem.2024.01.048","relation":{},"ISSN":["0735-6757"],"issn-type":[{"value":"0735-6757","type":"print"}],"subject":[],"published":{"date-parts":[[2024,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Differentiating hidradenitis suppurativa flare from infection in the emergency department and recommendations for transitioning care to the outpatient setting","name":"articletitle","label":"Article Title"},{"value":"The American Journal of Emergency Medicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ajem.2024.01.048","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}